Group One Trading, L.P. Viracta Therapeutics, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.38 - $2.29 $11,491 - $19,068	-8,327 Reduced 98.81%	100 $0
Q3 2022 Nov 09, 2022	SELL	$3.32 - $5.69 $332 - $569	-100 Reduced 1.17%	8,427 $36,000
Q1 2022 May 12, 2022	BUY	$2.23 - $4.76 $18,294 - $39,051	8,204 Added 2539.94%	8,527 $41,000
Q3 2021 Nov 12, 2021	BUY	$7.84 - $12.53 $2,532 - $4,047	323 New	323 $3,000

9.39M

5.9K

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $18.4M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.